Sex Hormones and Immunity to Infection 2009
DOI: 10.1007/978-3-642-02155-8_10
|View full text |Cite
|
Sign up to set email alerts
|

Sex Steroids and Risk of Female Genital Tract Infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2010
2010
2014
2014

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 116 publications
0
2
0
Order By: Relevance
“…Evidence in the literature suggests that high P 4 concentrations, such as those in the luteal phase and during pregnancy, are associated with increased HIV-1 shedding in cervical secretions (21,109,110) and increased susceptibility to HIV-1 infections (21,(111)(112)(113). Similarly, both human and animal studies suggest a link between high P 4 levels and increased risk of sexually transmitted diseases like HSV-2, Chlamydia, and Candidiasis (24,114). Considering that the concentrations of P 4 fluctuate due to reproductive processes (27,114,115), whereas the serum levels of MPA used as contraceptive peak after injection (4.5-65 nM) but then stay constant (ϳ 2.6 nM) for approximately 3 months, P 4 may induce transient inflammation of the ectocervical environment during times of high P 4 concentrations, although MPA may cause a more sustained inflammation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Evidence in the literature suggests that high P 4 concentrations, such as those in the luteal phase and during pregnancy, are associated with increased HIV-1 shedding in cervical secretions (21,109,110) and increased susceptibility to HIV-1 infections (21,(111)(112)(113). Similarly, both human and animal studies suggest a link between high P 4 levels and increased risk of sexually transmitted diseases like HSV-2, Chlamydia, and Candidiasis (24,114). Considering that the concentrations of P 4 fluctuate due to reproductive processes (27,114,115), whereas the serum levels of MPA used as contraceptive peak after injection (4.5-65 nM) but then stay constant (ϳ 2.6 nM) for approximately 3 months, P 4 may induce transient inflammation of the ectocervical environment during times of high P 4 concentrations, although MPA may cause a more sustained inflammation.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, both human and animal studies suggest a link between high P 4 levels and increased risk of sexually transmitted diseases like HSV-2, Chlamydia, and Candidiasis (24,114). Considering that the concentrations of P 4 fluctuate due to reproductive processes (27,114,115), whereas the serum levels of MPA used as contraceptive peak after injection (4.5-65 nM) but then stay constant (ϳ 2.6 nM) for approximately 3 months, P 4 may induce transient inflammation of the ectocervical environment during times of high P 4 concentrations, although MPA may cause a more sustained inflammation. Our results are consistent with a model whereby pregnant and pre-menopausal nonpregnant women in the luteal phase could be vulnerable to sexually transmitted diseases due to proinflammatory actions of P 4 via the GR, although women on depo-medroxyprogesterone acetate could be vulnerable at all times, but especially after injection, via the same mechanism.…”
Section: Discussionmentioning
confidence: 99%